Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
Tweet | ||
100 * ! | Mon, 8/5/2013, 8:30 AM - 10:20 AM | CC-520c | |
Opening the Doors to Open Source Programming in Drug Development — Invited Papers | |||
Section for Statistical Programmers and Analysts , Section on Statistical Computing | |||
Organizer(s): Vipin Arora, AbbVie, Inc. | |||
Chair(s): Stephen Wilson, FDA/CDER/OTS/OB/DBIII | |||
8:35 AM | Beyond SAS versus R: Making the Case for Open Source Software in Clinical Trials — Kevin Buhr, University of Wisconsin | ||
8:55 AM | Pharmaceutical Users of Software Exchange (PhUSE) - a quick overview — Michael Carniello, Takeda Global Research & Development Center, Inc. | ||
9:15 AM | Opening the Doors to Open Source Programming in Drug Development — Narinder K, Nangia, AbbVie , Inc. ; Annie Wang, Astellas | ||
9:30 AM | Open Source and Commercialized Open Source: Risks, Mitigations, and Upsides for Commercial Regulated R&D — Anthony Joseph Rossini, Novartis Pharma AG ; Vincent Carey, Harvard Medical School | ||
9:45 AM | Open Source Software in the Biopharma Industry: Challenges and Opportunities — Jose Carlos Pinheiro, Janssen R&D | ||
10:05 AM | Discussant: Jyoti Rayamajhi, Eli Lilly and Company | ||
10:15 AM | Floor Discussion |
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.